CD8A and neoplasm: Because PEG-MP9-aPDL1 incurred ICD and DAMPs, the recruited CD8+ T cells could be blocked by immune checkpoint inhibitor anti-PD-L1 peptide that contributes to the tumor immunosuppressive microenvironment.